IL-6 as a central driver of immune evasion in PDAC: from IDO-mediated tolerance to multi-pathway immunosuppression - Top-Institutions - MDSpire

IL-6 as a central driver of immune evasion in PDAC: from IDO-mediated tolerance to multi-pathway immunosuppression

  • By

  • Joyce Wang

  • Jolene Su Yi Tan

  • Vishal G. Shelat

  • Jackwee Lim

  • July 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Oncology

  • #3

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #4

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Oncology

  • #5

    Cold Spring Harbor Laboratory
    Cold Spring Harbor Laboratory

    Cold Spring Harbor, New York

    Key Differentiators

    • Oncology

Original Source(s)

IL-6 as a central driver of immune evasion in PDAC: from IDO-mediated tolerance to multi-pathway immunosuppression

  • by Joyce Wang, Jolene Su Yi Tan, Vishal G. Shelat, Jackwee Lim

  • July 7, 2026

Related Content

Predictive value of Ki-67 expression in predicting pathological response to neoadjuvant chemotherapy combined with immunotherapy in lung squamous cell carcinoma

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

  • by

  • July 7, 2026

  • 8 min
Head and neck squamous cell carcinoma with femoral metastasis: a case report and systematic review of current literature